<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39349926</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>01</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>03</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>30</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Post-COVID-19 condition symptoms among emergency department patients tested for SARS-CoV-2 infection.</ArticleTitle><Pagination><StartPage>8449</StartPage><MedlinePgn>8449</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">8449</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-024-52404-4</ELocationID><Abstract><AbstractText>Symptoms of the Post-COVID-19 Condition are often non-specific making it a challenge to distinguish them from symptoms due to other medical conditions. In this study, we compare the proportion of emergency department patients who developed symptoms consistent with the World Health Organization's Post-COVID-19 Condition clinical case definition between those who tested positive for Severe Acute Respiratory Syndrome Coronavirus-2 infection and time-matched patients who tested negative. Our results show that over one-third of emergency department patients with a proven acute infection meet Post-COVID-19 Condition criteria 3 months post-index visit. However, one in five test-negative patients who claim never having been infected also report symptoms consistent with Post-COVID-19 Condition highlighting the lack of specificity of the clinical case definition. Testing for SARS-CoV-2 during the acute phase of a suspected infection should continue until specific biomarkers of Post-COVID-19 Condition become available for diagnosis and treatment.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Archambault</LastName><ForeName>Patrick M</ForeName><Initials>PM</Initials><Identifier Source="ORCID">0000-0002-5090-6439</Identifier><AffiliationInfo><Affiliation>Department of Family Medicine and Emergency Medicine, Université Laval, Québec, QC, Canada. patrick.archambault@fmed.ulaval.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre de recherche intégrée pour un système de santé apprenant en santé et services sociaux, Centre intégré de santé et de services sociaux de Chaudière-Appalaches, Lévis, QC, Canada. patrick.archambault@fmed.ulaval.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VITAM - Centre de recherche en santé durable, Québec, QC, Canada. patrick.archambault@fmed.ulaval.ca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosychuk</LastName><ForeName>Rhonda J</ForeName><Initials>RJ</Initials><Identifier Source="ORCID">0000-0001-8019-5466</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, University of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Audet</LastName><ForeName>Martyne</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-9557-022X</Identifier><AffiliationInfo><Affiliation>Centre de recherche intégrée pour un système de santé apprenant en santé et services sociaux, Centre intégré de santé et de services sociaux de Chaudière-Appalaches, Lévis, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hau</LastName><ForeName>Jeffrey P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, The University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Graves</LastName><ForeName>Lorraine</ForeName><Initials>L</Initials><Identifier Source="ORCID">0009-0005-0699-7782</Identifier><AffiliationInfo><Affiliation>Patient Engagement Committee, Canadian COVID-19 Emergency Department Rapid Response Network, The University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Décary</LastName><ForeName>Simon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>École de réadaptation, Faculté de médecine et des sciences de la santé, Université de Sherbrooke, Sherbrooke, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perry</LastName><ForeName>Jeffrey J</ForeName><Initials>JJ</Initials><Identifier Source="ORCID">0000-0003-2134-9597</Identifier><AffiliationInfo><Affiliation>Department of Emergency Medicine, University of Ottawa, Ottawa, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ottawa Hospital Research Institute, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brooks</LastName><ForeName>Steven C</ForeName><Initials>SC</Initials><Identifier Source="ORCID">0000-0002-4592-4974</Identifier><AffiliationInfo><Affiliation>Department of Emergency Medicine, Queen's University, Kingston, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Public Health Sciences, Queen's University, Kingston, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morrison</LastName><ForeName>Laurie J</ForeName><Initials>LJ</Initials><Identifier Source="ORCID">0000-0001-8369-9774</Identifier><AffiliationInfo><Affiliation>Division of Emergency Medicine, Department of Medicine, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daoust</LastName><ForeName>Raoul</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-6507-0198</Identifier><AffiliationInfo><Affiliation>Département de médecine de famille et de médecine d'urgence, Université de Montréal, Montréal, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Département de médecine d'urgence, Hôpital du Sacré-Cœur-de-Montréal, Montréal, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yeom</LastName><ForeName>David Seonguk</ForeName><Initials>DS</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, The University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiemer</LastName><ForeName>Hana</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-6515-2799</Identifier><AffiliationInfo><Affiliation>Department of Emergency Medicine, Dalhousie University, Halifax, NS, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fok</LastName><ForeName>Patrick T</ForeName><Initials>PT</Initials><Identifier Source="ORCID">0000-0001-5787-5439</Identifier><AffiliationInfo><Affiliation>Department of Emergency Medicine, Dalhousie University, Halifax, NS, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McRae</LastName><ForeName>Andrew D</ForeName><Initials>AD</Initials><Identifier Source="ORCID">0000-0003-2743-4290</Identifier><AffiliationInfo><Affiliation>Department of Emergency Medicine, University of Calgary, Calgary, AB, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Community Health Sciences, University of Calgary, Calgary, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chandra</LastName><ForeName>Kavish</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Dalhousie Medicine New Brunswick, Saint John, NB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kho</LastName><ForeName>Michelle E</ForeName><Initials>ME</Initials><Identifier Source="ORCID">0000-0003-3170-031X</Identifier><AffiliationInfo><Affiliation>School of Rehabilitation Science, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Research Institute of St. Joe's Hamilton, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stacey</LastName><ForeName>Dawn</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-2681-741X</Identifier><AffiliationInfo><Affiliation>Ottawa Hospital Research Institute, Ottawa, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Nursing, University of Ottawa, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vissandjée</LastName><ForeName>Bilkis</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Faculty of Nursing, Université de Montréal, Montréal, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Menear</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Family Medicine and Emergency Medicine, Université Laval, Québec, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VITAM - Centre de recherche en santé durable, Québec, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mercier</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Family Medicine and Emergency Medicine, Université Laval, Québec, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VITAM - Centre de recherche en santé durable, Québec, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre de recherche du CHU de Québec-Université Laval, Québec, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Département de médecine d'urgence, Hôpital de l'Enfant-Jésus, Québec, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vaillancourt</LastName><ForeName>Samuel</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Emergency Medicine, Department of Medicine, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Emergency Medicine, St. Michael's Hospital, Unity Health Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aziz</LastName><ForeName>Samina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centre for Surveillance and Applied Research, Health Promotion and Chronic Disease Prevention Branch, Public Health Agency of Canada, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zakaria</LastName><ForeName>Dianne</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-8610-1248</Identifier><AffiliationInfo><Affiliation>Centre for Surveillance and Applied Research, Health Promotion and Chronic Disease Prevention Branch, Public Health Agency of Canada, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davis</LastName><ForeName>Phil</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, University of Saskatchewan, Saskatoon, SK, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dainty</LastName><ForeName>Katie N</ForeName><Initials>KN</Initials><AffiliationInfo><Affiliation>North York General Hospital, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paquette</LastName><ForeName>Jean-Sébastien</ForeName><Initials>JS</Initials><Identifier Source="ORCID">0000-0002-9524-6761</Identifier><AffiliationInfo><Affiliation>Department of Family Medicine and Emergency Medicine, Université Laval, Québec, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VITAM - Centre de recherche en santé durable, Québec, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leeies</LastName><ForeName>Murdoch</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, University of Manitoba, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goulding</LastName><ForeName>Susie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Patient Engagement Committee, Canadian COVID-19 Emergency Department Rapid Response Network, The University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>COVID Long-Haulers Support Group Canada, Oakville, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berger Pelletier</LastName><ForeName>Elyse</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Family Medicine and Emergency Medicine, Université Laval, Québec, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hohl</LastName><ForeName>Corinne M</ForeName><Initials>CM</Initials><Identifier Source="ORCID">0000-0002-9210-7838</Identifier><AffiliationInfo><Affiliation>Department of Emergency Medicine, The University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Canadian COVID−19 Emergency Department Rapid Response Network (CCEDRRN) investigators</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>Network of Canadian Emergency Researchers</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>Canadian Critical Care Trials Group investigators</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>447679</GrantID><Agency>Gouvernement du Canada | Canadian Institutes of Health Research (Instituts de Recherche en Santé du Canada)</Agency><Country /></Grant><Grant><GrantID>464947</GrantID><Agency>Gouvernement du Canada | Canadian Institutes of Health Research (Instituts de Recherche en Santé du Canada)</Agency><Country /></Grant><Grant><GrantID>466880</GrantID><Agency>Gouvernement du Canada | Canadian Institutes of Health Research (Instituts de Recherche en Santé du Canada)</Agency><Country /></Grant><Grant><GrantID>5357</GrantID><Agency>Saskatchewan Health Research Foundation (SHRF)</Agency><Country /></Grant><Grant><GrantID>COV024</GrantID><Agency>Genome British Columbia</Agency><Country /></Grant><Grant><GrantID>VAC007</GrantID><Agency>Genome British Columbia</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004636" MajorTopicYN="Y">Emergency Service, Hospital</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086742" MajorTopicYN="N">COVID-19 Testing</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Martin</LastName><ForeName>Ian</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wormsbecker</LastName><ForeName>Sean</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Purssell</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Graham</LastName><ForeName>Lee</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stachura</LastName><ForeName>Maja</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Scheuermeyer</LastName><ForeName>Frank</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Taylor</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brar</LastName><ForeName>Baljeet</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ting</LastName><ForeName>Daniel</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ohle</LastName><ForeName>Rob</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cheng</LastName><ForeName>Ivy</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yan</LastName><ForeName>Justin</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Clark</LastName><ForeName>Gregory</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Turner</LastName><ForeName>Joel</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grant</LastName><ForeName>Lars</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Robert</LastName><ForeName>Sébastien</ForeName><Initials>S</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>1</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>1</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>30</Day><Hour>23</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39349926</ArticleId><ArticleId IdType="pmc">PMC11442466</ArticleId><ArticleId IdType="doi">10.1038/s41467-024-52404-4</ArticleId><ArticleId IdType="pii">10.1038/s41467-024-52404-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization, WHO Coronavirus (COVID-19) dashboard, https://data.who.int/dashboards/covid19/cases.</Citation></Reference><Reference><Citation>Nordvig, A. S. et al. Brain fog in long COVID limits function and health status, independently of hospital severity and preexisting conditions. Front. Neurol.14, 1150096 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10213727</ArticleId><ArticleId IdType="pubmed">37251229</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallegos, M. et al. The impact of long Covid on people’s capacity to work. Ann. Work Expo. Health67, 801–804 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37253159</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul Garner: For 7 weeks I have been through a roller coaster of ill health, extreme emotions, and utter exhaustion. The BMJhttps://blogs.bmj.com/bmj/2020/05/05/paul-garner-people-who-have-a-more-protracted-illness-need-help-to-understand-and-cope-with-the-constantly-shifting-bizarre-symptoms/ (2020).</Citation></Reference><Reference><Citation>Powell, M. Living with Covid19. https://evidence.nihr.ac.uk/themedreview/living-with-covid19/10.3310/themedreview_41169 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.3310/themedreview_41169</ArticleId></ArticleIdList></Reference><Reference><Citation>A clinical case definition of post-COVID-19 condition by a Delphi consensus, 6 October 2021. https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis, H. E., McCorkell, L., Vogel, J. M. &amp; Topol, E. J. Long COVID: major findings, mechanisms and recommendations. Nat. Rev. Microbiol.21, 133–146 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz, G. M. et al. Understanding how post–COVID-19 condition affects adults and health care systems. JAMA Health Forum4, e231933–e231933 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37418268</ArticleId></ArticleIdList></Reference><Reference><Citation>McNaughton, C. D. et al. Post-acute health care burden after SARS-CoV-2 infection: a retrospective cohort study. CMAJ194, E1368–E1376 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9616149</ArticleId><ArticleId IdType="pubmed">36252983</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Global COVID-19 Clinical Platform Case Report Form (CRF) for Post COVID condition (post COVID-19 CRF). https://www.who.int/publications/i/item/global-covid-19-clinical-platform-case-report-form-(crf)-for-post-covid-conditions-(post-covid-19-crf-) (2021).</Citation></Reference><Reference><Citation>Abdul Rashid, M. R. et al. COVID-19 pandemic fatigue and its sociodemographic, mental health status, and perceived causes: a cross-sectional study nearing the transition to an endemic phase in Malaysia. Int. J. Environ. Res. Public Health20, 4476 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10001764</ArticleId><ArticleId IdType="pubmed">36901486</ArticleId></ArticleIdList></Reference><Reference><Citation>Are, E. B., Song, Y., Stockdale, J. E., Tupper, P. &amp; Colijn, C. COVID-19 endgame: from pandemic to endemic? Vaccination, reopening and evolution in low- and high-vaccinated populations. J. Theor. Biol.559, 111368 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9686052</ArticleId><ArticleId IdType="pubmed">36436733</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu, R. Y. K., Szeto, K. C., Wong, I. O. L. &amp; Chung, P. H. A global scale COVID-19 variants time-series analysis across 48 countries. Front. Public Health11, 1085020 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10173412</ArticleId><ArticleId IdType="pubmed">37181700</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Maaden, T. et al. Prevalence and severity of symptoms 3 months after infection with SARS-CoV-2 compared to test-negative and population controls in the Netherlands. J. Infect. Dis.227, 1059–1067 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36477364</ArticleId></ArticleIdList></Reference><Reference><Citation>Hastie, C. E. et al. Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland study. Nat. Commun.13, 1–9 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9556711</ArticleId><ArticleId IdType="pubmed">36224173</ArticleId></ArticleIdList></Reference><Reference><Citation>Venturelli, S. et al. Surviving COVID-19 in Bergamo province: a post-acute outpatient re-evaluation. Epidemiol. Infect.149, e32 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7873454</ArticleId><ArticleId IdType="pubmed">33461632</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldman, D. E., Boudrias, M.-H. &amp; Mazer, B. Long COVID symptoms in a population-based sample of persons discharged home from hospital. Can. J. Public Health113, 930–939 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9491248</ArticleId><ArticleId IdType="pubmed">36131218</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, C. et al. Global prevalence of post-Coronavirus Disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review. J. Infect. Dis.226, 1593–1607 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Jennings, G., Monaghan, A., Xue, F., Mockler, D. &amp; Romero-Ortuño, R. A systematic review of persistent symptoms and residual abnormal functioning following acute COVID-19: ongoing symptomatic phase vs. Post-COVID-19 syndrome. J. Clin. Med. Res.10, 5913 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8708187</ArticleId><ArticleId IdType="pubmed">34945213</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkodaymi, M. S. et al. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis. Clin. Microbiol. Infect.28, 657–666 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8812092</ArticleId><ArticleId IdType="pubmed">35124265</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff, D. et al. Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: a systematic review. JAMA Netw. Open4, e2128568 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Huerne, K. et al. Epidemiological and clinical perspectives of long COVID syndrome. Am. J. Med. Open9, 100033 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9846887</ArticleId><ArticleId IdType="pubmed">36685609</ArticleId></ArticleIdList></Reference><Reference><Citation>O’Mahoney, L. et al. The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis. EClinicalMedicine55, 101762 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang, D. H., Roy, D. J., Gu, B. J., Hassett, L. C. &amp; McCoy, R. G. Postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection: a state-of-the-art review. JACC Basic Transl. Sci.6, 796–811 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8442719</ArticleId><ArticleId IdType="pubmed">34541421</ArticleId></ArticleIdList></Reference><Reference><Citation>Natarajan, A. et al. A systematic review and meta-analysis of long COVID symptoms. Syst. Rev.12, 88 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10220332</ArticleId><ArticleId IdType="pubmed">37245047</ArticleId></ArticleIdList></Reference><Reference><Citation>Post-COVID-19 Condition in Canada: What we know, what we don’t know, and a framework for action (Pre-Report). https://science.gc.ca/site/science/en/office-chief-science-advisor/initiatives-covid-19/post-covid-19-condition-canada-what-we-know-what-we-dont-know-and-framework-action-pre-report (2022).</Citation></Reference><Reference><Citation>Government of Canada &amp; Canada, S. Long-term symptoms in Canadian adults who tested positive for COVID-19 or suspected an infection, January 2020 to August 2022. https://www150.statcan.gc.ca/n1/daily-quotidien/221017/dq221017b-eng.htm (2022).</Citation></Reference><Reference><Citation>Post-COVID-19 Condition in Canada: What we know, what we don’t know, and a framework for action. https://science.gc.ca/site/science/en/office-chief-science-advisor/initiatives-covid-19/post-covid-19-condition-canada-what-we-know-what-we-dont-know-and-framework-action (2023).</Citation></Reference><Reference><Citation>Spatz, E. S. et al. Three-month symptom profiles among symptomatic adults with positive and negative severe acute respiratory syndrome coronavirus 2 tests: a prospective cohort study from the INSPIRE group. Clin. Infect. Dis.76, 1559–1566 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11361781</ArticleId><ArticleId IdType="pubmed">36573005</ArticleId></ArticleIdList></Reference><Reference><Citation>Selvakumar, J. et al. Prevalence and characteristics associated with post–COVID-19 condition among nonhospitalized adolescents and young adults. JAMA Netw. Open6, e235763–e235763 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10064252</ArticleId><ArticleId IdType="pubmed">36995712</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaweethai, T. et al. Development of a definition of postacute sequelae of SARS-CoV-2 infection. JAMA329, 1897–1995 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10214179</ArticleId><ArticleId IdType="pubmed">37278994</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnusson, K., Turkiewicz, A., Flottorp, S. A. &amp; Englund, M. Prevalence of long COVID complaints in persons with and without COVID-19. Sci. Rep.13, 1–9 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10100609</ArticleId><ArticleId IdType="pubmed">37055494</ArticleId></ArticleIdList></Reference><Reference><Citation>Marossy, A. et al. A study of universal severe acute respiratory syndrome coronavirus 2 RNA testing among residents and staff in a large group of care homes in South London. J. Infect. Dis.223, 381–388 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7499645</ArticleId><ArticleId IdType="pubmed">32889532</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandhi, M., Yokoe, D. S. &amp; Havlir, D. V. Asymptomatic transmission, the Achilles’ Heel of current strategies to control Covid-19. N. Engl. J. Med.382, 2158–2160 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7200054</ArticleId><ArticleId IdType="pubmed">32329972</ArticleId></ArticleIdList></Reference><Reference><Citation>Akinbami, L. J. et al. SARS-CoV-2 serology and self-reported infection among adults—national health and nutrition examination survey, United States, August 2021-May 2022. MMWR Morb. Mortal. Wkly. Rep.71, 1522–1525 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9721142</ArticleId><ArticleId IdType="pubmed">36454698</ArticleId></ArticleIdList></Reference><Reference><Citation>Canadian Blood Services. COVID-19 seroprevalence increasing. https://www.blood.ca/en/stories/latest-study-results-show-upward-shift-covid-19-prevalence (2021)</Citation></Reference><Reference><Citation>Caminsky, N. Seroprevalence in Canada. COVID-19 Immunity Task Force. https://www.covid19immunitytaskforce.ca/seroprevalence-in-canada/ (2021).</Citation></Reference><Reference><Citation>Doroshenko, A. et al. Decline of influenza and respiratory viruses with COVID-19 public health measures: Alberta, Canada. Mayo Clin. Proc.96, 3042–3052 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8450272</ArticleId><ArticleId IdType="pubmed">34863395</ArticleId></ArticleIdList></Reference><Reference><Citation>Groves, H. E. et al. The impact of the COVID-19 pandemic on influenza, respiratory syncytial virus, and other seasonal respiratory virus circulation in Canada: a population-based study. Lancet Regional Health—Am.1, 100015 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8285668</ArticleId><ArticleId IdType="pubmed">34386788</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaichana, U. et al. Definition of post–COVID-19 condition among published research studies. JAMA Netw. Open6, e235856–e235856 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10077105</ArticleId><ArticleId IdType="pubmed">37017970</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian, A. et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat. Med.28, 1706–1714 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Horberg, M. A. et al. Post-acute sequelae of SARS-CoV-2 with clinical condition definitions and comparison in a matched cohort. Nat. Commun.13, 1–13 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9556630</ArticleId><ArticleId IdType="pubmed">36224218</ArticleId></ArticleIdList></Reference><Reference><Citation>Saniasiaya, J., Islam, M. A. &amp; Abdullah, B. Prevalence of olfactory dysfunction in coronavirus disease 2019 (COVID-19): a meta-analysis of 27,492 patients. Laryngoscope131, 865–878 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7753439</ArticleId><ArticleId IdType="pubmed">33219539</ArticleId></ArticleIdList></Reference><Reference><Citation>Renaud, M. et al. Clinical outcomes for patients with anosmia 1 year after COVID-19 diagnosis. JAMA Netw. Open4, e2115352–e2115352 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8226421</ArticleId><ArticleId IdType="pubmed">34165581</ArticleId></ArticleIdList></Reference><Reference><Citation>Paderno, A. et al. Olfactory and gustatory outcomes in COVID-19: a prospective evaluation in nonhospitalized subjects. Otolaryngol. Head. Neck Surg.163, 1144–1149 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7331108</ArticleId><ArticleId IdType="pubmed">32600175</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsampasian, V. et al. Risk factors associated with post−COVID-19 condition: a systematic review and meta-analysis. JAMA Intern. Med.183, 566–580 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10037203</ArticleId><ArticleId IdType="pubmed">36951832</ArticleId></ArticleIdList></Reference><Reference><Citation>Sylvester, S. V. et al. Sex differences in sequelae from COVID-19 infection and in long COVID syndrome: a review. Curr. Med. Res. Opin.41, 1391–1399 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35726132</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte, K. I. et al. Age, sex and previous comorbidities as risk factors not associated with SARS-CoV-2 infection for long COVID-19: a systematic review and meta-analysis. J. Clin. Med. Res.11, 7314 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9787827</ArticleId><ArticleId IdType="pubmed">36555931</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai, F. et al. Female gender is associated with long COVID syndrome: a prospective cohort study. Clin. Microbiol. Infect.28, 611.e9–611.e16 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference><Reference><Citation>Newson, L., Lewis, R. &amp; O’Hara, M. Long Covid and menopause—the important role of hormones in Long Covid must be considered. Maturitas152, 74 (2021).</Citation></Reference><Reference><Citation>Ortona, E. &amp; Malorni, W. Long COVID: to investigate immunological mechanisms and sex/gender related aspects as fundamental steps for tailored therapy. Eur. Respir. J. 59, 2102245 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8462012</ArticleId><ArticleId IdType="pubmed">34531277</ArticleId></ArticleIdList></Reference><Reference><Citation>Samulowitz, A., Gremyr, I., Eriksson, E. &amp; Hensing, G. ‘Brave Men’ and ‘Emotional Women’: a theory-guided literature review on gender bias in health care and gendered norms towards patients with chronic pain. Pain Res. Manag. 2018, 6358624 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5845507</ArticleId><ArticleId IdType="pubmed">29682130</ArticleId></ArticleIdList></Reference><Reference><Citation>D’Souza, A. et al. Men’s gendered experiences of rehabilitation and recovery following traumatic brain injury: a reflexive thematic analysis. Neuropsychol. Rehabil. 10.1080/09602011.2020.1822882 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">32960149</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin, S. J. et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. J. Med. Virol.93, 1013–1022 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>The Writing Committee for the COMEBAC Study Group. et al. Four-month clinical status of a cohort of patients after hospitalization for COVID-19. JAMA325, 1525–1534 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7970386</ArticleId><ArticleId IdType="pubmed">33729425</ArticleId></ArticleIdList></Reference><Reference><Citation>Heesakkers, H. et al. Clinical outcomes among patients with 1-year survival following intensive care unit treatment for COVID-19. JAMA327, 559–565 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8787680</ArticleId><ArticleId IdType="pubmed">35072716</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradley, M. C. et al. Systemic corticosteroid use for COVID-19 in US outpatient settings from April 2020 to August 2021. JAMA327, 2015 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8994158</ArticleId><ArticleId IdType="pubmed">35394487</ArticleId></ArticleIdList></Reference><Reference><Citation>Covello, R. D. et al. Meta-analysis of glucocorticoids for COVID-19 patients not receiving oxygen. NEJM Evidence. 10.1056/EVIDoa2200283 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">38320047</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshikawa, M. &amp; Asaba, K. Educational attainment decreases the risk of COVID-19 severity in the European population: a two-sample Mendelian randomization study. Front. Public Health9, 673451 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8212884</ArticleId><ArticleId IdType="pubmed">34150709</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlis, R. H. et al. Prevalence and correlates of long COVID symptoms among US adults. JAMA Netw. Open5, e2238804–e2238804 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9614581</ArticleId><ArticleId IdType="pubmed">36301542</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson, E. J. et al. Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat. Commun.13, 1–11 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9240035</ArticleId><ArticleId IdType="pubmed">35764621</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan, D. &amp; Pareek, M. Toward a universal definition of post–COVID–19 condition—how do we proceed? JAMA Netw. Open6, e235779–e235779 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37017975</ArticleId></ArticleIdList></Reference><Reference><Citation>Damant, R. W. et al. Reliability and validity of the post COVID-19 condition stigma questionnaire: a prospective cohort study. eClinicalMedicine55, 101755 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9694932</ArticleId><ArticleId IdType="pubmed">36447641</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli, M. et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study. Lancet Infect. Dis.22, 00460–00466 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzolini, E. et al. Association between BNT162b2 vaccination and long COVID after infections not requiring hospitalization in health care workers. JAMA328, 676 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9250078</ArticleId><ArticleId IdType="pubmed">35796131</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly, Z., Bowe, B. &amp; Xie, Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat. Med.28, 1461 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundberg-Morris, L. et al. Covid-19 vaccine effectiveness against post-covid-19 condition among 589 722 individuals in Sweden: population based cohort study. BMJ383, e076990 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10666099</ArticleId><ArticleId IdType="pubmed">37993131</ArticleId></ArticleIdList></Reference><Reference><Citation>Grewal, R. et al. Effectiveness of a fourth dose of covid-19 mRNA vaccine against the omicron variant among long term care residents in Ontario, Canada: test negative design study. BMJ378, e071502 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9257064</ArticleId><ArticleId IdType="pubmed">35793826</ArticleId></ArticleIdList></Reference><Reference><Citation>Menegale, F. et al. Evaluation of waning of SARS-CoV-2 vaccine-induced immunity: a systematic review and meta-analysis. JAMA Netw. open6, e2310650 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10157431</ArticleId><ArticleId IdType="pubmed">37133863</ArticleId></ArticleIdList></Reference><Reference><Citation>Marra, A. R. et al. The effectiveness of coronavirus disease 2019 (COVID-19) vaccine in the prevention of post–COVID-19 conditions: A systematic literature review and meta-analysis. Antimicrob. Stewardship Healthc. Epidemiol.2, e192 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9726631</ArticleId><ArticleId IdType="pubmed">36505947</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Burden of Disease Long COVID Collaborators. et al. Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA328, 1604–1615 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>Dun-Dery, F. et al. Post-COVID-19 condition in children 6 and 12 months after infection. JAMA Network Open6, (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10755606</ArticleId><ArticleId IdType="pubmed">38153737</ArticleId></ArticleIdList></Reference><Reference><Citation>Jimeno-Almazán, A. et al. Relationship between the severity of persistent symptoms, physical fitness, and cardiopulmonary function in post-COVID-19 condition. A population-based analysis. Intern. Emerg. Med.17, 2199–2208 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9335466</ArticleId><ArticleId IdType="pubmed">35904700</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahmer, T. et al. Severity, predictors and clinical correlates of post-COVID syndrome (PCS) in Germany: a prospective, multi-centre, population-based cohort study. eClinicalMedicine51, 101549 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9289961</ArticleId><ArticleId IdType="pubmed">35875815</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano, J. B., Murthy, S., Marshall, J. C., Relan, P. &amp; Diaz, J. V. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 22, e102–e107 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Government of Canada &amp; Canada, S. Impacts of COVID-19 on Canadians—testing and vaccination, February 21 to March 13, 2022. https://www150.statcan.gc.ca/n1/daily-quotidien/220407/dq220407a-eng.htm (2022).</Citation></Reference><Reference><Citation>Hohl, C. M. et al. Development of the Canadian COVID-19 emergency department rapid response network population-based registry: a methodology study. CMAJ Open9, E261–E270 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8096396</ArticleId><ArticleId IdType="pubmed">33731427</ArticleId></ArticleIdList></Reference><Reference><Citation>Hohl, C. M. et al. The CCEDRRN COVID-19 Mortality Score to predict death among nonpalliative patients with COVID-19 presenting to emergency departments: a derivation and validation study. Can. Med. Assoc. Open Access J.10, E90–E99 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9259439</ArticleId><ArticleId IdType="pubmed">35135824</ArticleId></ArticleIdList></Reference><Reference><Citation>McRae, A. D. et al. CCEDRRN COVID-19 Infection Score (CCIS): development and validation in a Canadian cohort of a clinical risk score to predict SARS-CoV-2 infection in patients presenting to the emergency department with suspected COVID-19. BMJ Open11, e055832 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8640195</ArticleId><ArticleId IdType="pubmed">34857584</ArticleId></ArticleIdList></Reference><Reference><Citation>Hohl, C. M. et al. Sensitivity and diagnostic yield of the first SARS-CoV-2 nucleic acid amplification test performed for patients presenting to the hospital. JAMA Netw. Open5, e2236288–e2236288 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9557877</ArticleId><ArticleId IdType="pubmed">36223119</ArticleId></ArticleIdList></Reference><Reference><Citation>Hohl, C. M. et al. Treatments, resource utilization, and outcomes of COVID-19 patients presenting to emergency departments across pandemic waves: an observational study by the Canadian COVID-19 Emergency Department Rapid Response Network (CCEDRRN). CJEM24, 397–407 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8972682</ArticleId><ArticleId IdType="pubmed">35362857</ArticleId></ArticleIdList></Reference><Reference><Citation>Bola, R. et al. Patient-reported health outcomes of SARS-CoV-2–tested patients presenting to emergency departments: a propensity score–matched prospective cohort study. Public Health215, 1 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9712064</ArticleId><ArticleId IdType="pubmed">36587446</ArticleId></ArticleIdList></Reference><Reference><Citation>von Elm, E. et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet370, 806–808(2007).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2034723</ArticleId><ArticleId IdType="pubmed">17947786</ArticleId></ArticleIdList></Reference><Reference><Citation>Archambault, P. M. et al. Recommendations for patient engagement in patient-oriented emergency medicine research. CJEM20, 435–442 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29690943</ArticleId></ArticleIdList></Reference><Reference><Citation>Staniszewska, S. et al. GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in research. BMJ358, j3453 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5539518</ArticleId><ArticleId IdType="pubmed">28768629</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor, J. M. Choosing the number of controls in a matched case-control study, some sample size, power and efficiency considerations. Stat. Med.5, 29–36 (1986).</Citation><ArticleIdList><ArticleId IdType="pubmed">3961313</ArticleId></ArticleIdList></Reference><Reference><Citation>Archambault, P. M. et al. Accuracy of self-reported COVID-19 vaccination status compared with a public health vaccination registry in Québec: observational diagnostic study. JMIR Public Health Surveill.9, e44465 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10278735</ArticleId><ArticleId IdType="pubmed">37327046</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones, R. et al. Risk predictors and symptom features of long COVID within a broad primary care patient population including both tested and untested patients. Pathol. Oncol. Res.12, 93–104 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8366779</ArticleId><ArticleId IdType="pubmed">34408531</ArticleId></ArticleIdList></Reference><Reference><Citation>Canadian COVID-19 Emergency Department Rapid Response Network. https://www.ccedrrn.com/ (2024).</Citation></Reference><Reference><Citation>Roger Stoddard (he/him)1958-2022. Canadian Medical Associationhttps://www.cma.ca/get-involved/patient-voice/roger-stoddard-hehim1958-2022.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>